HLB Life Science Co., Ltd. (KOSDAQ:067630)
6,550.00
-80.00 (-1.21%)
May 8, 2025, 12:39 PM KST
HLB Life Science Revenue
In the year 2024, HLB Life Science had annual revenue of 102.24B KRW with 4.34% growth. HLB Life Science had revenue of 28.68B in the quarter ending December 31, 2024, with 21.79% growth.
Revenue
102.24B
Revenue Growth
+4.34%
P/S Ratio
7.90
Revenue / Employee
705.10M
Employees
145
Market Cap
807.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 102.24B | 4.25B | 4.34% |
Dec 31, 2023 | 97.99B | -1.60B | -1.61% |
Dec 31, 2022 | 99.59B | 46.10B | 86.17% |
Dec 31, 2021 | 53.49B | -38.30B | -41.73% |
Dec 31, 2020 | 91.80B | -22.22B | -19.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Korea Electric Power | 93.40T |
Korea Gas | 38.39T |
Korea District Heating | 3,570.31B |
SK eternix | 398.58B |
Korea Electric Power Industrial Development | 367.53B |
Samchully Co.,Ltd | 5,120.53B |
INVENI | 1,160.35B |
Daesung Energy | 995.13B |